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Why was the cohort set up?
In 2000, the Africa Centre Demographic Information
System (ACDIS),1 a demographic surveillance platform,
was established in the uMkhanyakude district of rural
KwaZulu-Natal, one of the world’s most intensely HIV-
affected regions. Due to massive public health efforts that
have increased access to antiretroviral therapy in this pop-
ulation over the past 15 years, HIV-associated mortality is
declining and life expectancy is rising.2 Tuberculosis (TB)
has overtaken HIV as the leading cause of mortality in
South Africa,3 and non-communicable disease (NCD)
morbidity and mortality are rising nationally4 and across
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sub-Saharan Africa.5 In response to the changing scientific
and public health priorities posed by the intersection of the
HIV, TB and NCDs epidemics, the Africa Health Research
Institute (AHRI) expanded the Africa Centre Demographic
Information System to form the Population Intervention
Programme (PIP) in 2017.6 In 2018, Vukuzazi (‘Wake up and
know yourself’ in isiZulu) was established as a nested closed
cohort of PIP. Vukuzazi offered community-based health phe-
notyping and comprehensive bio-sampling to all resident
adult (15 years) members of the southern part of the PIP
study area, while building upon the existing wealth of demo-
graphic and HIV information collected over the previous
20 years. The objective of the programme was to determine
the prevalence and overlap of infectious diseases and NCDs
in the population 20 years into the HIV epidemic.
Additionally, the programme aimed to create a data, image
and bio-sample repository that could be used to understand
the host, pathogen, social and environmental determinants of
specific states of health and disease in the population, and
provide the basis for follow-up intervention studies.
The Vukuzazi programme was conducted in the southern
part of the PIP area,6 (Figure 1) which corresponds with the
original Africa Centre Demographic Information System
surveillance area, near the market town of Mtubatuba. The
area covers 438 km2 and includes a population of approxi-
mately 12 000 households with 65 000 residents (people
who spend most of their nights in the surveillance area) and
30 000 non-residents (people who are household members
but spend most of their nights outside the surveillance area).
About 40% of resident members are younger than
15 years. Households in the southern PIP have been under
continuous demographic surveillance since 2000.1 In 2003,
annual HIV serosurveys were added to describe the demo-
graphic social and health impacts of the rapidly progressing
HIV epidemic.1 The PIP area has 11 peripheral primary
health care clinics (of which seven are in the southern part),
and one district hospital lies outside the study area. The lo-
cation of the area covered by the Vukuzazi programme, sites
where the mobile camp enrolled participants and other fea-
tures of the area are shown in Figure 1.
The scientific objectives and proposed activities of the
Vukuzazi programme were conceptualized and developed
in consultation with the AHRI Community Advisory
Board (CAB) and other local stakeholders, including
elected and traditional leaders and representatives of the
local Department of Health (DoH).
Who is in the cohort?
Ethical approval for the study was obtained from the
Ethics Committees of the University of KwaZulu-Natal
(BE560/17), London School of Hygiene & Tropical
Medicine (#14722), the Partners Institutional Review
Board (2018P001802), and from the University of
Alabama at Birmingham (#300007237).
The eligible study population consisted of all resident
members of the southern PIP area who were aged 15 years
during the baseline data collection (May 2018–March 2020).
Non-resident members were excluded from participation.
Participants were recruited in a two-stage process
(Figure 2): (i) a household visit during which all eligible
participants were invited to participate (the invitation pro-
cess); and (ii) a formal informed consent and enrolment
process at the Vukuzazi health camp (Figure 3).
Invitation process at the participant’s homestead
This component was scheduled approximately 1 week be-
fore the Vukuzazi mobile health camp visited an area. We
Key Features
• The Vukuzazi programme was established to address public health responses and scientific priorities in light of the
convergence of the HIV, tuberculosis and non-communicable disease epidemics in South Africa.
• The programme is a nested closed cohort of the Population Intervention Programme and performed community-
based health phenotyping in the uMkhanyakude district of rural KwaZulu-Natal, South Africa, while simultaneously
creating a data, image and bio-sample repository.
• Baseline data collection began in May 2018 and was completed in March 2020, having enrolled 50% of the eligible
population aged 15 years and over [18 041: 12 230 female (68%) female and 5811 male (32%)].
• The community-based phenotyping consisted of: a nurse-administered health questionnaire on personal history of
HIV, tuberculosis, diabetes, hypertension, cancer, tobacco and alcohol use; quality of life; anthropometric
measurements and blood pressure readings; venous blood sample for clinical testing and bio-banking; digital chest
radiograph, sputum collection and sputum mycobacterial tests; as well as rectal swab collection for biobanking.
• Data for secondary analysis, access to the biological samples and imaging data are available through request on this
link: [https://data.ahri.org].
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Figure 1 Location of the study area, showing the Vukuzazi sites within the demographic surveillance area
Figure 2 Components of the Vukuzazi programme
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used the demographic surveillance data to populate an eligi-
bility list, compiled by fieldworkers at the most recent
household survey but no more than 1 year before the
Vukuzazi visit. Based on this list, the community-based
study team visited the household and invited all eligible
members to the Vukuzazi health camp. The team explained
the rationale for the study, using an information brochure
written in isiZulu which was left with the household.
Additionally, the team left personalized invitation cards for
each eligible member which included the individual’s unique
PIP identification number, a quick response (QR) barcode,
appointment date and the location of the Vukuzazi mobile
health camp. If no residents were home when a household
was visited, three visit attempts were conducted before a
household was considered non-contactable.
Informed consent and enrolment at the Vukuzazi
mobile health camp
During the 22-month study data collection period, the
Vukuzazi mobile health camp moved through the PIP area
with the goal of conducting procedures within two kilo-
metres of all eligible homesteads. Vukuzazi camp sites
were selected based on accessibility, sufficient space and
mobile connectivity. Permission was sought from the local
traditional authorities and leaders before selection of the fi-
nal sites. The mobile health camp stayed on average 2 days
at each location. In total, the camp was set up at 78 sites
over the observation period (Figure 1). Participants pre-
sented to the health camp with their unique invitation
card. After verification of their identity, they proceeded to
the next station for the informed consent process and an
explanation of the study components, including the risks
and benefits of participation, as well as information about
storage of samples for genetic analyses and future research.
Those who consented were given a barcoded wristband
which functioned as a unique identifier during their
Vukuzazi camp interaction, checking their identifiers at
each station.
Recruitment
About 39 000 individuals were eligible 1 year before data
collection. At the moment of data collection, about 3000
of them had died or moved out of the study area (Figure
4). This resulted in 36 097 individuals eligible for enrol-
ment, of whom approximately three-quarters were
Figure 3 The Vukuzazi mobile health camp
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contacted and accepted the invitation to visit the Vukuzazi
mobile camp (about one-quarter were unable to be con-
tacted, and of the contacted individuals only 2% refused
the invitation). Among the 26 795 individuals who ac-
cepted the invitation, however, approximately one-quarter
of eligible participants did not appear at the Vukuzazi
camp, resulting in 18 041 individuals (50.0% of the eligi-
ble population) who enrolled in the Vukuzazi programme.
The Vukuzazi programme enrolled participants across the
age range of the eligible population, with slight under-repre-
sentation of the younger ages (Table 1). Females outnum-
bered males in the underlying population structure (Figure 5)
Figure 4 Recruitment and participation in the Vukuzazi programme
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and enrolled in higher proportions than males (Figure 6).
Most participants resided in a rural (64%) or peri-urban
(31%) area of the study area and had very high rates of un-
employment (57%, Table 1). They were less highly educated,
had lower rates of employment, were less likely to have out-
migrated during the past 5 years and had a lower socioeco-
nomic score compared with eligible non-participants. They
were also more likely to have visited a clinic in the past year
and to have ever consented to home-based HIV counselling
and testing during the individual surveys (Table 1).
Table 1 Demographic characteristics of Vukuzazi participants, non-participants and eligible population
Characteristic Vukuzazi participants Non-participants Eligible population P-valueb
N¼18 041a N¼18 056a N¼36 097a
Age group <0.001
15–24 4977 (28%) 6072 (34%) 11 049 (31%)
25–34 3371 (19%) 4483 (25%) 7854 (22%)
35–44 2634 (15%) 3119 (17%) 5753 (16%)
45–54 2240 (12%) 1952 (11%) 4192 (12%)
55–64 2353 (13%) 1320 (7%) 3673 (10%)
65þ 2466 (14%) 1110 (6%) 3576 (10%)
Sex <0.001
Male 5811 (32%) 9154 (51%) 14 965 (41%)
Female 12 230 (68%) 8902 (49%) 21 132 (59%)
Education <0.001
None 4532 (25%) 3855 (22%) 8387 (24%)
Less than secondary 6737 (38%) 5173 (29%) 11 910 (33%)
Secondary and above 6666 (37%) 8719 (49%) 15 385 (43%)
Missing 106 309 415
Marital status <0.001
Single 3757 (24%) 4015 (27%) 7772 (26%)
Married/living as married 9647 (62%) 9761 (66%) 19 408 (64%)
Separated/divorced/widowed 2155 (14%) 1042 (7%) 3197 (11%)
Missing 2482 3238 5720
Employment statusc <0.001
Unemployed 3887 (57%) 3420 (37%) 7307 (45%)
Employedd 2979 (43%) 5921 (63%) 8900 (55%)
Missing 11 175 8715 19 890
Residence location <0.001
Urban 950 (5%) 1899 (11%) 2849 (8%)
Peri-urban 5599 (31%) 6214 (35%) 11 813 (33%)
Rural 11 436 (64%) 9863 (55%) 21 299 (59%)
Missing 56 80 136
Socioeconomic statuse <0.001
Lowest 2118 (12%) 1606 (9.4%) 3724 (11%)
Low 4712 (27%) 3727 (22%) 8439 (24%)
Middle 4216 (24%) 3716 (22%) 7932 (23%)
High 3115 (18%) 3122 (18%) 6237 (18%)
Highest 3307 (19%) 4833 (28%) 8140 (24%)
Missing 573 1052 1625
Out-migration during the past 5 years 2315 (13%) 3714 (21%) 6029 (17%) <0.001
Any clinic visit in the past year (ClinicLink) 9561 (53%) 5940 (33%) 15 501 (43%) <0.001
Ever consented for HIV testing during the
individual surveys?
7389 (41%) 3904 (22%) 11 293 (31%) <0.001
aStatistics presented: n (%).
bStatistical tests performed: chi square test of independence.
cEmployment status calculated among members of the resident population in the labour force.
dDepartment of Statistics South Africa’s strict definition of unemployment.
eSocioeconomic status: an asset-based index created using principal components analysis (PCA) on a standard list of questions about household items, water
source, toilet type and electricity source.
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How often have they been followed up?
Vukuzazi is nested within the AHRI PIP,6 which will allow
for both demographic and health system follow-up of par-
ticipants. Participants will be observed prospectively three
times per year through the PIP demographic surveillance
activities, which will record changes to their household res-
idence, demographic and vital status. In addition, partici-
pants’ prospective clinical data will be collected through
clinic and hospital data systems established through PIP.6,7
In 2017, AHRI implemented the ClinicLink system6,7 to
collect the date of and self-reported reasons for all visits by
individuals who attend one of the 11 clinics in the PIP area
(whether self-referred or referred to care after screening
tests). In this ClinicLink system, data are electronically
captured and individuals are linked to their PIP identifica-
tion number at the time of the visit. Data on all admissions
to Hlabisa District Hospital (the local referral hospital) are
collected through the Hospital Information System.
Successful referrals or clinic attendance were monitored
through ClinicLink. Successful referrals from Vukuzazi
were entered into the relevant DoH care pathway by an
AHRI professional nurse based at the health facility.
Finally, in accordance with ongoing PIP activities, ver-
bal autopsy will be performed for all deaths occurring in
the population.6 These follow-up mechanisms allow
Vukuzazi’s 2018–20 data to serve as a baseline assessment
of a longitudinal cohort that includes clinical outcome as-
sessment. Additional nested disease- and health behaviour-
specific protocols will provide additional specific follow-
up information.8 Long-term plans for the cohort will be
driven both by scientific priorities and funding; currently
we are considering repeating clinical measures every 3 to 5
years.
What has been measured?
The majority of measurements and samples were collected
at the Vukuzazi mobile health camp; participants with ab-
normal measurements or results had a follow-up home
visit with additional data collected at that time. The partic-
ipant flow through the Vukuzazi mobile camp is summa-
rized in Figure 3 and the data types collected during the
two visits are described in Table 2. The mobile health
camp consisted of module elements that could be used in
parallel to accommodate up to 100 participants per day
(Figure 3).
After completing the informed consent procedure, par-
ticipants submitted two self-administered rectal swabs, and
women of childbearing age submitted a urine sample to as-
certain pregnancy status. An enrolled nurse then adminis-
tered a health questionnaire (see Supplementary material,
available as Supplementary data at IJE online) on personal
history of HIV, tuberculosis, diabetes, hypertension, can-
cer, tobacco and alcohol use,9 symptoms of TB (cough, fe-
ver, night sweats of any duration or unintended weight
loss),10 and quality of life.11
Figure 5 Population pyramid of the eligible population and Vukuzazi participants (at time of invitation or recruitment)
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Next, a research nurse performed anthropometric meas-
urements (Table 2) and blood pressure readings following
the World Health Organization STEPwise protocol.9 After
30 min of inactivity, three blood pressure measurements,
with 5 min resting time in between, were collected using
portable electronic devices (OMRON Healthcare, Model
M6). Participants then moved to the blood station where
38.5 ml of blood was collected. All participants except for
pregnant women underwent a digital chest X-ray (Canon
CXDI-NE), performed in a mobile X-ray unit also equipped
with an artificial intelligence computer-aided detection for
TB (CAD4TB) score system (Version 5), which detects lung
field abnormalities in real time.12 Any participant with one
of the four cardinal TB symptoms, or a CAD4TB score
above a pre-defined threshold or who was pregnant, was
asked to submit a sputum sample. After completion of the
chest X-ray and/or sputum collection, the visit to the health
camp was completed at the exit station, where data were
checked for completeness, and participants received a food
parcel and reimbursement voucher (of the value of R 100—
equivalent to approximately USD$6).
All chest X-rays were interpreted by CAD4TBv5 and,
within 14 days, underwent a standardized interpretation by
an experienced radiologist. The study physician reviewed all
data from questionnaires, anthropomorphic and blood pres-
sure measurements and laboratory and radiological testing,
and initiated appropriate clinical management.
Participants with normal or expected findings (e.g.
known HIV-positive on antiretroviral therapy with a sup-
pressed viral load) received an SMS informing them that
their results were normal. Participants who shared a phone
or who had invalid test results received a phone call to en-
sure that the correct participant was contacted. Participants
with abnormal findings (elevated blood pressure in someone
not on antihypertensive treatment, or an X-ray suggestive of
TB) or testing results (new HIV diagnosis, positive
GeneXpert Mycobacterium tuberculosis/Rifampin (Xpert
for MTB), glycated haemoglobin (HbA1c) >6.5%) were
booked for an appointment for a home-based follow-up
visit by a study nurse.
At the follow-up visits, the following measurements
were made (Table 2): three blood pressure measurements
(performed as described above) for people with elevated
blood pressure at the Vukuzazi health camp; and point-of-
care fasting blood glucose for people with HbA1c >6.5%.
On the basis of the Vukuzazi health camp results and,
when appropriate, the repeated measurements, referrals
were made for further care at one of the local primary
health care clinics or hospital.
In addition to the data collected through the Vukuzazi
health camp, the following data on Vukuzazi participants
are available through linkage with other data systems (Table
2): detailed demographic data (including education, socio-
economic status, marital status), sexual behaviour, house-
hold composition, structure and familial relationships
(including family trees), household location (including geo-
spatial coordinates), self-reported hospital attendance and
diagnosis data, verbal autopsy data collected through the
PIP surveillance,6 TB- and antiretroviral therapy-related
data through Three Interlinked Electronic Register
(TIER.net)13 and Covid-19-related data through the Covid-
19 Surveillance protocol.8
What has it found?
The data generated from the Vukuzazi study will create a
clinical research platform for future longitudinal studies of
HIV, TB, NCDs and multimorbidity. Use of mobile clinics
and mobile X-ray units for multi-disease health screening
enabled the study to enrol people within reach of their
place of residence, thereby increasing participation rates.
The study demonstrated the usefulness of digital health
tools (such as mobile data collection tablets, digital chest
X-rays) in collecting clinical data without need for paper
records, thereby minimizing data entry and transfer errors
and challenges associated with paper-based data collec-
tion. A key advantage of electronic data collection is speed
of accessibility of data from multiple sources. We were
able to return test results and conduct clinical review of all
Figure 6 Contact and Vukuzazi health camp attendance rates by sex for
eligible members of the demographic surveillance population






/ije/advance-article/doi/10.1093/ije/dyab229/6446138 by guest on 01 D
ecem
ber 2021
Table 2 Data collected at the Vukuzazi health camp, during the follow-up visit at home and through linkage with other systems
Topic Details Who
Vukuzazi Health Camp




Symptoms Cardinal TB symptoms, COPD
symptoms
All
Alcohol and tobacco use WHO STEPS questionnaire All
Quality of life EuroQOL EQ5D All








Urine specimen Pregnancy Urine beta-HCG All women 15–49 years
Rectal swab Microbiome Storage for future testing All
Blood specimens HIV Ab/Ag All
Viral Load, CD4 Positive HIV Ab/Ag
HbA1c All
Plasma, serum, dried blood spot,
PAXGene, blood smear, buffy
coat
Storage for future testing All who consent to storage of
specimens
Sputum TB GeneXpert Mtb/RIF and liquid
mycobacterial culture
Pregnant women and individuals
with CAD4TB score above
threshold





Storage for future testing All with a positive liquid culture
Decontaminated sputum Storage for future testing All
Imagery Digital chest X-ray All except for pregnant women
Follow-up visit at home
Measurements Blood pressure 3 measurements (WHO STEPS
protocol)
Elevated blood pressure (140 or
90) and not known hypertensive
during health camp visit






Household demographics Household members (dates of
birth, sex, relationship to house-
hold head, marital status, resi-
dency status), births, deaths, in-
and out-migration
All households in PIP
Household socioeconomic data Household assets, Household in-
frastructure (water, sanitation,
electricity), food security, expe-
rience of violence
All households in PIP
Individual socioeconomic data Education, employment All individuals who are members
of households in PIP
Individual—HIV status HIV status All residents aged 15 years in PIP
Self-reported: HIV status, when
last tested negative/positive, cur-
rently on ART
(Continued)
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participants, leading to linkage to care for participants
with abnormal results. The combination of decentralized
mobile data collection and efficient participant-friendly
data systems resulted in high rates of successful completion
of study components.
The focus on multimorbidity was also a departure from
many previous biomedical studies in the region, which often
have a limited scope related to HIV and/or tuberculosis. The
broad range of conditions considered might have helped re-
duce stigma associated with participation in the study.14
Acceptance of community health screening and of
the biobank platform
A qualitative sub-study of participant and non-participant
experiences in Vukuzazi found that most participants had
a positive impression of the research and their participa-
tion, although they emphasized the health screening com-
ponents over the research components and had limited
understanding of genetics and biobanking.14 Non-
participants largely cited scheduling conflicts as their rea-
son for not participating.
Prevalence of infectious and non-communicable
disease
Among the four conditions assessed, HIV had the highest
overall population prevalence (34.2%). Previously undiag-
nosed active TB was prevalent in 1.0%, lifetime TB in
21.8%, elevated blood pressure in 23.0% and elevated
blood glucose in 8.5% of the population. Appropriate
treatment and resulting control of disease was highest for
HIV (76.3%) and lower for elevated blood pressure
(40.0%), active tuberculosis (31.3%) and elevated blood
glucose (6.9%).15 Distribution of the four diseases was het-
erogeneously distributed between sexes, across the life
course and geospatially. Rates of multimorbidity (more
than one of the two diseases) were high and increased with
age. Among the disease risk factors assessed, obesity had
the highest overall prevalence (30.1%).
Health-related quality of life
The contrast between controlled HIV and uncontrolled
non-communicable diseases also appeared to have effects
on health-related quality of life. The presence of controlled
Table 2 Continued
Topic Details Who
Individual—sexual behaviour Pregnancy history (women), con-
traceptive use (women), number
of children fathered (men), sex-
ual activity, attitudes to condom
use
All residents aged 15 years in PIP




All residents aged 15 years in PIP
TB diagnosis/treatment circum-
cised (men)
ClinicLink Clinic attendance Date of clinic visit, self-reported
reason for clinic attendance
Individuals attending one of 11




Hospital admissions Admission date, discharge date,
ward admitted to, ICD-10 diag-
nosis, discharge status
All admissions to Hlabisa hospital
except for routine deliveries
TIER.net Electronic patient records for indi-
viduals on ART
Clinic visits for ART care, viral
load, CD4 counts, ART regimen
at initiation, changes in ART
regimen
Individuals on ART in any of 17
clinics in the Hlabisa health sub-
district and Hlabisa hospital
Electronic patient records for indi-
viduals on TB treatment
Clinic visits for TB care, TB
regimen
Individuals on TB treatment in any
of 17 clinics in the Hlabisa
health sub-district and Hlabisa
hospital
TB, tuberculosis; WHO STEPS, World Health Organization STEPwise; COPD, chronic obstructive pulmonary disease; BMI, body mass index; MUAC, mid-
upper arm circumference; urine beta-HCG, urine beta human chorionic gonadotropin; HIV Ab/Ag, HIV antibody/antigen; GeneXpert Mtb/RIF, GeneXpert
Mycobacterium tuberculosis/Rifampin; CAD4TB, Computer-Aided Detection for TB; HbA1c, glycated haemoglobin; PIP, Population Intervention Programme;
ICD-10, International Statistical Classification of Diseases and Related Health Problems 10th Revision; ART, antiretroviral therapy.
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HIV was unexpectedly associated with better overall self-
reported health (manuscript under review). This was in
contrast to having more non-infectious conditions
(whether controlled or not), which was associated with
worse overall self-reported health. In South Africa and sim-
ilar settings, where intersecting non-communicable and in-
fectious disease epidemics are prevalent, incorporating
multimorbidity into health care strategies and improving
the integration of care may improve overall well-being.
Asymptomatic TB
During the baseline survey we found that 1.0% of the
screened population had microbiologically proven TB, and
that 80% of these individuals were asymptomatic.
Individuals newly diagnosed with active TB in community-
based screening have fewer symptoms, compared with people
diagnosed at health facilities (manuscript under review).
Asymptomatic TB eludes traditional symptom-based TB
screening algorithms, but in most cases it is identifiable by
chest X-ray abnormality.16 In addition to often being asymp-
tomatic, TB detected through community-based screening
may have its own spectrum of radiological features compared
with TB diagnosed in clinics and hospitals, making it a dis-
tinct use case for automated imaging algorithms.
Screening for hypertension and diabetes
We found low positive predictive values of single screening
measurements of blood pressure and blood glucose to de-
tect hypertension and diabetes when compared with se-
quential testing on separate days. Single measurement
screening for hypertension and diabetes resulted in approx-
imately a 50% rate of potentially unnecessary or prema-
ture referrals into the health sector for these conditions
(manuscript under review). These findings suggest that re-
peated testing for NCDs should be considered during
community-based screenings, particularly in settings when
there is concern for over-burdening health systems with
potentially unnecessary referrals.
What are the main strength and
weaknesses?
Strengths
The Vukuzazi programme has demonstrated that demo-
graphic surveillance programmes can be effectively used to
support multi-disease health characterization of popula-
tions within a demographic surveillance area. The PIP sur-
veillance provided a comprehensive sampling frame,
enabling us to determine and quantify participation and
disease prevalence rates. Data collected in Vukuzazi can be
linked to previous and prospective demographic, socioeco-
nomic, health and behavioural data routinely collected as
part of the annual surveillance. The large size and com-
pleteness of the linked data, image and bio-sample reposi-
tories create the possibility for further detailed studies into
the biological and social determinants of health and disease
in the population, and interventions to improve outcomes.
Weaknesses
We only enrolled half of the eligible participants. Contact
rates were low among participants who were unavailable
due to work, school and other social commitments.
Various strategies such as varying recruitment times and
working on weekends were employed, without signifi-
cantly improving enrolment rates of difficult-to-enrol
demographic sub-populations (e.g. working men). Non-
participation could be non-random which needs to be
considered in the interpretation of disease prevalence esti-
mates. However, the existing wealth of information that
has been collected on the eligible population since 2000
allows us to examine the difference between Vukuzazi par-
ticipants and non-participants using statistical techniques
to take into account non-response. This can be explored in
future analyses and follow-up studies.
Can I get hold of the data? And of the
biological samples or imaging data? Where
can I find out more?
Researchers who would like to use the data for secondary
analyses, or use the biological samples or imaging data,
must complete a letter of intent accessible on this link:
[https://data.ahri.org/index.php/home], in which they ex-
press their interest and outline the intended use of the data
or biological samples. The Vukuzazi Scientific Steering
Committee will review requests on an ongoing basis and in-
vite proposals for collaboration. Vukuzazi data are accessi-
ble through the AHRI Data Repository after approval and
completion of a data use agreement. Data documentation
including questionnaires used for data collection and a full
data dictionary are available on the AHRI Data Repository.
Supplementary Data
Supplementary data are available at IJE online
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